From tighter hemodynamic definitions to a first-in-class activin signaling inhibitor, a nearly 30-year PH veteran says the field has never had more to offer patients — or more complexity to manage.
Susanne McDevitt, DNP
Advertisement
Susanne McDevitt, DNP, ACNP-BC, Acute Care Nurse Practitioner in the Pulmonary Hypertension Program at Michigan Medicine, University of Michigan, Ann Arbor
Articles by Susanne McDevitt, DNP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
SimpleScreen CRC Blood Test Meets Endpoints in Clinical Validation Study
2
First-Line Biologic Selection in High-Risk Psoriasis: The Role of IL-23 Inhibition
3
Shared Decision-Making, Adherence, and Future Directions in Pediatric IBS-C and Functional Constipation
4
Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B
5